BCAX
NASDAQ · Biotechnology
Bicara Therapeutics Inc
$22.01
-0.63 (-2.78%)
Open$23.06
Previous Close$22.64
Day High$23.34
Day Low$21.95
52W High$30.99
52W Low$10.30
Volume—
Avg Volume535.6K
Market Cap1.54B
P/E Ratio—
EPS$-3.09
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
-34.1% upside
Current
$22.01
$22.01
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 181.36M | 184.14M | 159.71M |
| Net Income | -39,755,825 | -41,476,631 | -32,201,263 |
| Profit Margin | -21.9% | -22.5% | -20.2% |
| EBITDA | -52,674,751 | -54,395,580 | -46,526,832 |
| Free Cash Flow | -41,149,249 | -44,589,211 | -37,987,097 |
| Rev Growth | +5.9% | -5.2% | -5.4% |
| Debt/Equity | 0.58 | 0.56 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |